Typical pneumonia among human immunodeficiency virus-infected patients in public hospitals in southern Ethiopia
Open Access
- 30 July 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (7) , e0307780
Abstract
Background: Typical pneumonia is a pressing issue in the treatment of human immunodeficiency virus (HIV) patients, especially in Sub-Saharan Africa, where it remains a significant menace. Addressing this problem is crucial in improving health outcomes and the reduction of the burden of diseases in this vulnerable category of patients. Objective: To determine the prevalence of community-acquired typical pneumonia among HIV patients in Public Hospitals in southern Ethiopia. Methods: A cross-sectional study was done among 386 HIV patients clinically suspected of typical pneumonia attending the anti-retroviral therapy (ART) clinics of two hospitals from March to September 2022. A pretested structured questionnaire was employed to collect the demographic, clinical, and behavioral data. Sputum samples were collected and inspected for bacteria following standard procedures, and antimicrobial susceptibility testing was performed employing the Kirby-Bauer disk diffusion method. Besides, extended-spectrum β-lactamase (ESβL) and carbapenemase-producing Gram-negative bacteria were inspected by the double disk synergy test and modified carbapenem inactivation method. Descriptive and inferential statistical analyses were also done. Results: Overall, 39.1% (151/386) of sputum cultures (95% Confidence Interval: 32.4–44) were bacteriologically positive. A total of 151 bacteria were identified, comprising 72.8% (n = 110) of Gram-negative bacteria. The predominant isolate was Klebsiella pneumoniae (25.8%, n = 39), followed by Staphylococcus aureus (17.9%, n = 27); 59.6% (n = 90) of the entire isolates were multidrug-resistant (MDR). Forty percent (11/27) of S. aureus were methicillin-resistant S. aureus (MRSA), and 28.1% (n = 31) and 20.9% (n = 23) of Gram-negative bacteria were extended-spectrum beta-lactamases (ESBL) and carbapenemase producers, respectively. Occupational status, alcohol consumption, cluster of differentiation4 (CD4) Thymocyte cell count < 350, interruption of trimethoprim-sulfamethoxazole prophylaxis and antiretroviral treatment, and recent viral load ≥ 150 were found statistically significant. Conclusion: The higher rates of MDR, MRSA, ESBL, and carbapenem-resistant Enterobacterales (CRE) indicate that bacterial pneumonia is a vexing problem among HIV patients and therefore it is advisable to implement an antimicrobial stewardship program in the study area.Keywords
This publication has 39 references indexed in Scilit:
- The association between antimicrobial resistance and HIV infection: a systematic review and meta-analysisClinical Microbiology and Infection, 2021
- Prevalence of bacterial pneumonia among HIV-Seropositive patients in East Africa: ReviewCogent Medicine, 2021
- Prevalence of enteric bacteria and enteroparasites in human immunodeficiency virus-infected individuals with diarrhoea attending antiretroviral treatment clinic, Arba Minch General Hospital, southern EthiopiaNew Microbes and New Infections, 2020
- Current therapeutics and prophylactic approaches to treat pneumonia2016
- Incidence and Risk Factors for Invasive Pneumococcal Disease in HIV-Infected and Non-HIV-Infected Individuals Before and After the Introduction of Combination Antiretroviral Therapy: Persistent High Risk Among HIV-Infected Injecting Drug UsersClinical Infectious Diseases, 2014
- Bacterial Pneumonia, HIV Therapy, and Disease Progression among HIV‐Infected Women in the HIV Epidemiologic Research (HER) StudyClinical Infectious Diseases, 2006
- Global strategies to prevent bacterial pneumonia in adults with HIV diseaseThe Lancet Infectious Diseases, 2004
- PREVALENCE OF BACTERIAL AND FUNGAL AGENTS CAUSING LOWER RESPIRATORY TRACT INFECTIONS IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTIONIndian Journal of Medical Microbiology, 2004
- Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendationsAIDS, 2001
- Community‐Acquired Pneumonia in Adults: Guidelines for ManagementClinical Infectious Diseases, 1998